Table 1.
Summary of anti-depressive-like behavior effect of rodent models with astaxanthin.
Tested Parameters | Animal models | AST dosage | Effect | Reference |
---|---|---|---|---|
FST, TST, LA, NO, iNOS, nNOS, eNOS, COX-2, NF-κB p65, IL-1β, IL-6, TNF-α, and related mRNA. | Male ICR mice (4–6weeks, 20–22 g) were injected with LPS (0.83 mg/kg). | Trans-AST (20,40,80 mg/kg). | Trans-AST has counteracted the depressive-like behavior of LPS-induced depression mice. | [65] |
OFT, TST, Hole-board test, and oxidative stress estimation. | Adult (6 months) female swiss albino mice were injected intraperitoneally LPS(300 μg/kg). | 2 mg/kg. | AST has counteracted the LPS-exposure induced behavioral deficits. | [66] |
OFT, EMP, FST, LA, OGTT, pERK, pCREB, pAKT, and BDNF in the PFC. | Male Sprague-Dawley rats (300–350 g) were injected STZ (25 mg/kg). | 7.5, 15, 25 mg/kg/d. | AST has counteracted comorbid diabetes and depression disorders. | [67] |
OFT, FST, TST, neuronal morphology, p-Pi3K, p-Akt, p-GSK3β, and p-CREB. | Adult male Kunming mice (35–40 g) were injected omethoate (5 mg/kg) every day for 4 weeks. | 50 mg/kg/d. | LiCl + AST treatment could counteract depression-like symptom. | [21] |
The modified TST, the modified FST, GFAP, cleaved caspase-3, IL-6, IL-1β, and COX-2. | Adult male ICR mice (18–20 g) were injected intraperitoneally STZ (150 mg/kg). | 25 mg/kg/d. | AST has an anti-depressant effect on diabetic mice. | [68] |
CLET, UALST, FST, Bdnf mRNA, Arc mRNA. | Audlt male (175–200 g) and femal (125–150 g) Wistar-Unilever rats. | Krill oil 0.2 g/rat/d. | Krill oil improved learning processes and provided antidepressant-like effects. | [69] |
Note: FST: forced swimming test, TST: tail suspension test, LA: locomotor activity, NO: nitric oxide, iNOS: inducible nitric oxide synthase, nNOS: neuronal NOS, eNOS: endothelial NOS, OFT: open field test, EMP: elevated plus maze, OGTT: oral glucose tolerance test, CLET: conditioned light extinction test, UALST: unavoidable aversive light stimulus.